IL95059A - Nitropurentuine preparation - Google Patents

Nitropurentuine preparation

Info

Publication number
IL95059A
IL95059A IL9505990A IL9505990A IL95059A IL 95059 A IL95059 A IL 95059A IL 9505990 A IL9505990 A IL 9505990A IL 9505990 A IL9505990 A IL 9505990A IL 95059 A IL95059 A IL 95059A
Authority
IL
Israel
Prior art keywords
nitrofurantoin
particulates
monohydrate
composition
administration
Prior art date
Application number
IL9505990A
Other languages
English (en)
Hebrew (he)
Other versions
IL95059A0 (en
Original Assignee
Norwich Eaton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Eaton Pharma filed Critical Norwich Eaton Pharma
Publication of IL95059A0 publication Critical patent/IL95059A0/xx
Publication of IL95059A publication Critical patent/IL95059A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Saccharide Compounds (AREA)
IL9505990A 1989-07-25 1990-07-12 Nitropurentuine preparation IL95059A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/385,646 US5178880A (en) 1989-07-25 1989-07-25 Liquid suspensions of nitrofurantoin

Publications (2)

Publication Number Publication Date
IL95059A0 IL95059A0 (en) 1991-06-10
IL95059A true IL95059A (en) 1994-07-31

Family

ID=23522290

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9505990A IL95059A (en) 1989-07-25 1990-07-12 Nitropurentuine preparation

Country Status (11)

Country Link
US (1) US5178880A (de)
EP (1) EP0410517B1 (de)
AT (1) ATE97806T1 (de)
AU (1) AU635948B2 (de)
CA (1) CA2020812C (de)
DE (1) DE69004882T2 (de)
DK (1) DK0410517T3 (de)
ES (1) ES2060931T3 (de)
IE (1) IE63814B1 (de)
IL (1) IL95059A (de)
NZ (1) NZ234635A (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5084984B2 (ja) * 1999-02-17 2012-11-28 シーエスエル、リミテッド 免疫原複合体およびそれに関する方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL171628C (nl) * 1950-05-29 Inst Francais Du Petrole Inrichting voor het uitzenden van akoestische golven in een vloeibaar milieu.
US3401221A (en) * 1964-08-25 1968-09-10 Norwich Pharma Co Treatment of urinary tract infection
US4122157A (en) * 1977-03-04 1978-10-24 Richardson-Merrell Inc. Nitrofurantoin sustained release tablet
DE2714065A1 (de) * 1977-03-30 1978-10-12 Boehringer Mannheim Gmbh Instillationszubereitung
US4370313A (en) * 1981-10-26 1983-01-25 Eaton Laboratories, Inc. Nitrofurantoin dosage form
US4959384A (en) * 1985-10-24 1990-09-25 Norwich Eaton Pharmaceuticals, Inc. Use of nitrofurantoin for the treatment and prophylaxis of gastrointestinal disorders
US4798725A (en) * 1986-06-16 1989-01-17 Norwich Eaton Pharmaceuticals, Inc. Sustained release capsule
US4772473A (en) * 1986-06-16 1988-09-20 Norwich Eaton Pharmaceuticals, Inc. Nitrofurantoin dosage form

Also Published As

Publication number Publication date
NZ234635A (en) 1993-10-26
ES2060931T3 (es) 1994-12-01
IE902693A1 (en) 1991-02-27
IE63814B1 (en) 1995-06-14
AU5975290A (en) 1991-01-31
DE69004882T2 (de) 1994-05-19
EP0410517A1 (de) 1991-01-30
ATE97806T1 (de) 1993-12-15
IL95059A0 (en) 1991-06-10
EP0410517B1 (de) 1993-12-01
DE69004882D1 (de) 1994-01-13
US5178880A (en) 1993-01-12
DK0410517T3 (da) 1994-02-07
CA2020812C (en) 1995-08-01
CA2020812A1 (en) 1991-01-26
AU635948B2 (en) 1993-04-08

Similar Documents

Publication Publication Date Title
DE60100750T2 (de) NEUE KRISTALLINE FORM VON N-[4-[2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO[2,3-d]-PYRIMIDIN-5-YL)ETHYL]BENZOYL]-L-GLUTAMINSÄURE UND VERFAHREN FÜR IHRE HERSTELLUNG
KR100318168B1 (ko) 리루졸을포함하는뉴로-aids치료를위한제약학적조성물
JPH01131117A (ja) 徐放性を有する安定水性懸濁液
JP2009514856A (ja) 医薬品ガリウム組成物及び方法
EA027869B1 (ru) Стабилизированная композиция такролимуса
US6342530B1 (en) Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt
UA72198C2 (en) Hydrate 5-[4-[2- (n-methyl-n- (2-pyridyl)amino) ethoxy]benzyl] thiazolidyn -2, 4-dione, maleic acid salts as pharmaceutical preparation
EP0864579B1 (de) Wismutsalze von Antibiotika der Moenomycin-Gruppe, Verfahren zu ihrer Herstellung, ihre Verwendung und solche Salze enthaltende Arzneimittel
CA2244213A1 (en) Buffer systems for stabilizing pharmaceutical preparations
US5332832A (en) Nitrofurantoin crystals
EP0412592B1 (de) Nitrofurantoinkristalle
EP0410517B1 (de) Flüssige Nitrofurantoinsuspension
US8865227B2 (en) Metal carbonate particles and methods of making thereof
AU650889B2 (en) Process for preparing aqueous suspension
EP2896625B1 (de) Cokristall von piperacillin-natrium und sulbactam-natrium und herstellungsverfahren dafür sowie pharmazeutische zusammensetzungen damit und verwendungen davon
WO1994023711A1 (de) Stabile ketamin-lösungen
SK16542002A3 (sk) Nové prípravky alfa-(2,4-disulfofenyl)-N-terc-butylnitrónu
EP0944612B1 (de) N-(4-acetyl-1-piperazinyl)-4-fluorobenzamidhydrat
SK14822000A3 (sk) Forma vi 5,6-dichlór-2-(izopropylamino)-1-(beta-l-ribofuranozyl)- 1h-benzimidazolu, spôsob jej prípravy, farmaceutický prostriedok s jej obsahom a jej použitie
DE102007018552A1 (de) Aufbewahrungssystem für Temozolomid
PT835653E (pt) Composicoes de antiacido liquidas
KR20240013733A (ko) 카바메이트 화합물을 포함하는 경구용 수성 현탁액 제형

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees